GLP-1 (Semaglutide) vs. Cagrilintide: Cognitive Comparison

For cognitive optimization, GLP-1 (Semaglutide) and Cagrilintide serve different neurological functions. GLP-1 (Semaglutide) is primarily indicated for significant weight loss via appetite suppression and metabolic improvement., while Cagrilintide excels at appetite control and weight management, especially synergistic with glp-1 agonists.. The choice depends on the specific cognitive goal — focus enhancement, anxiety reduction, neuroprotection, or sleep quality improvement.

CNS delivery route is a critical consideration: intranasal administration bypasses the blood-brain barrier via the olfactory nerve, providing faster and more direct CNS access than subcutaneous injection. For both compounds, physician supervision and regular cognitive assessments are recommended to optimize protocols.